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Take four
neuroscientists
Colin Blakemore
What is your advice to a neuroscience
PhD student? Think long and hard
about whether you want to commit
yourself to a career in scientific
neuroscience. There are limited
resources, grants, jobs and ideas.
The sort of people who can’t live
without research are the sort of
people who will have the enthusiasm
to continue. Also, it is very easy to
get bogged down in the intricacies of
the brain. Never forget that the brain
is a cognitive machine, not just a
piece of tissue. That is especially
relevant to neurogeneticists, who will
look at a gene in isolation from
everything else. 
What, in your opinion, is the greatest
unanswered question? What exactly
are qualia? Qualia are the qualities of
conscious experience — the redness
of red, for example. But what are
they in physical terms? For example,
think in terms of explaining the
conscious experience of the bat. We
may be able to give a description of
the conscious thought of a bat, but
we will never be able to experience
what it is to be that bat.
Colin Blakemore works on vision and the
early development of the brain at Oxford
University, UK.
Richard Frackowiak
What is your greatest unanswered
question? I’m working on it. In
science, it is definitely how the brain
is functionally organized.
Consciousness is part of it, but it’s the
broader, more fundamental question.
The fundamental belief or
assumption is that everything we do,
all our emotions, feelings, fears, are
the product of the brain, in one way or
another. How they are produced is
just fascinating, and of course critical
to understanding diseases of the
brain, of which there are many, and
many of which are devastating. I
suppose one of my fears would be
motor neurone disease or early
dementia.
Richard Frackowiak pioneered the study of
the brain using non-invasive imaging
techniques, including fMRI. He is at the
Institute of Neurology in London, UK.
Michael Gazzaniga
What is your advice to a neuroscience
PhD student? Turn off the e-mail.
There is a whole change in the
culture; they are victims of easy-
access information. The fact is that
success is still based on long, hard
hours in the lab.
What is your greatest unanswered
question? Getting any sense of how
neuroscience will actually explain
consciousness.
Michael Gazzaniga is a leader in the field of
cognitive neuroscience. He works at
Dartmouth College, USA.
Steven Pinker
What is your advice to a neuroscience
PhD student? Don’t confine your
learning to the academic discipline
called ‘neuroscience’. You picked the
brain to study, rather than the spleen,
because it is the seat of thinking and
feeling. So learn about thinking and
feeling from the other disciplines
that study them: psychology,
linguistics, artificial intelligence,
philosophy of the mind,
anthropology, ethology, economics.
What is your greatest unanswered
question? How did language first
evolve?
Steven Pinker works on language and its
relation to mind and brain at the
Massachusetts Institute of Technology, USA.
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Maxim V. Dorovkov
The vast majority of eukaryotic
protein kinases have a similar
catalytic domain structure consisting
of twelve conserved subdomains [1].
We, and others, have recently
reported the existence in eukaryotes
of protein kinases with a completely
different structure [2–5]. We cloned
and sequenced cDNAs encoding
elongation factor-2 kinase (eEF-2
kinase) [5], a ubiquitous protein
kinase involved in the regulation of
protein synthesis [6]. The catalytic
domain of eEF-2 kinase does not
display any homology to the
catalytic domains of the
conventional eukaryotic protein
kinases [5]. It is, however, strikingly
similar to the catalytic domain of
myosin heavy chain kinase A
(MHCK A) from Dictyostelium [2,3].
In order to analyze how
widespread this novel class of
protein kinases is, we performed
extensive database searches for
proteins with homology to the 
eEF-2 kinase/MHCK A catalytic
domain. No homologous proteins
were found in any prokaryotic
organisms or in unicellular
eukaryotes, including Saccharomyces
cerevisiae, the genome of which has
now been completely sequenced.
Similarly, this type of protein kinase
catalytic domain has not yet been
detected among plant proteins. In
Caenorhabditis elegans, the genome of
which is almost completely
sequenced, only one such protein
has been found, and it is eEF-2
kinase itself. In Dictyostelium, there
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are at least three proteins that have a
strong similarity to the eEF-2 kinase
catalytic domain, two of which are
MHCK A and a protein kinase
called MHCK B, which can also
phosphorylate myosin heavy chains
in vitro [7]. The third protein was
recently identified from a genetic
screen for morphological mutants
(W.F. Loomis, personal
communication) in which the
disrupted gene was named mhkC
(GenBank accession number
AF079447). The physiological
substrate for MhkC is as 
yet unknown. 
In searching the mouse and
human expressed sequence tag
(EST) databases, we identified
several ESTs with homology to the
eEF-2 kinase/MHCK A catalytic
domain. Clones corresponding to
these ESTs were sequenced. The
sequences obtained were used to
search the EST database for
overlapping clones, and the longest
of these were sequenced. From this
analysis, it became clear that, in
mammals, there are at least three
more proteins with a strong similarity
to the eEF-2 kinase catalytic
domain. We named two of these
proteins ‘heart kinase’ and
‘melanoma kinase’ because the
corresponding EST clones were
from mouse heart and mouse
melanoma cDNA libraries,
respectively. The third protein we
named ‘chromosome 4 kinase’
because we found that one of the
bacterial articificial chromosome
(BAC) clones of human genomic
DNA from chromosome 4, the
sequence of which was recently
deposited in GenBank, contained
the gene for this protein. 
The new sequences enabled us
to identify the consensus sequence
of this novel type of protein kinase
catalytic domain. An alignment of
the catalytic domains of human 
eEF-2 kinase, C. elegans eEF-2
kinase, MHCK A and B, MhkC and
the mammalian eEF-2-kinase-
related proteins is shown in Figure 1.
Altogether there are 20 positions in
the alignment that are identical in all
eight proteins, and there are 57
amino acids that are identical in at
least six out of the eight proteins.
Eight subdomains (I–VIII) can be
identified; there is no significant
homology between these eight
subdomains and any of the twelve
subdomains of the conventional
protein kinases. Subdomain VI
contains a typical Walker type B
motif, which consists of four
hydrophobic amino acids followed
by an aspartate residue [8]. This
motif is present in various proteins
catalyzing ATP-triggered reactions
and is involved in the coordination of
Mg2+ bound to the phosphates of
ATP [9]. In addition, subdomain
VIII contains a glycine-rich motif
that is typical of ATP-binding sites
in the catalytic domain of
conventional protein kinases,
although in those protein kinases it
is located at the extreme amino
terminus of the catalytic domain. 
Why does Nature use such
unusual kinases to phosphorylate
eEF-2 and myosin heavy chains? We
suggest that the explanation may be
found in their mechanism of
substrate recognition. It is well-
known that the substrate specificity
of both serine/threonine and
tyrosine protein kinases is
determined predominantly by the
primary structure around the
phosphorylation site rather than by
secondary or tertiary structure. As
was originally reported by Small,
Chou and Fasman [10],
phosphorylation sites in proteins
often occur in predicted β turns.
Subsequent studies, including X-ray
structure data, demonstrated that
phosphoacceptor sites for
conventional protein kinases are
usually located in turns, loops or
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Figure 1
Sequence alignment of the catalytic domains
of human (H.) eEF-2 kinase (EF-2K), 
C. elegans (C.e.) eEF-2 kinase, MHCK A,
MHCK B, MhkC, and hypothetical mammalian
eEF-2-kinase-related proteins predicted from
the sequencing of mouse and human EST
clones. Heart kinase and melanoma kinase
are so named because the corresponding
mouse EST clones were obtained from those
tissues (GenBank accession numbers
AA140393 and AA138771). Chromosome 4
kinase (Ch 4 K) is so named because the
gene for this protein is located on human
chromosome 4 (GenBank accession number
AC004049). Amino acids identical in at least
six out of the eight sequences are shown in
blue. Conserved hydrophobic amino acids 
(o in the consensus sequence) are shown 
in red. Roman numerals represent the eight
subdomains. 
I
H. EF-2K	 124 WLDDEVLIKMASQPFGRGAMRECFRTKKLSNFLHAQ---------------------------QWKGASNYVAKRYIEPVD--------
C.e. EF-2K	 110 WTEDIVDVRLHPDSFARGAMRECYRLKKCSKHGTSQ---------------------------DW--SSNYVAKRYICQVD--------
MHCK A	 572 WIRLSMKLKVERKPFAEGALREAYHTVSLGVGTDENYPLGTTTKLFPPIEMISPISKNNEAMTQLKNGTKFVLKLYKKEAE--------
MHCK B	 132 WTCTATLVKVEPVPFAEGAFRKAYHTLDLSKSGA---------------------------------SGRYVSKIGKK-----------
MhkC	 48 WTHSIVCVSIEKTPFAKGSCRTAHKLKDWS-----------------------------------QPDQGLVGKFSTNKK---------
Heart K	 189 GDHLRGQISTEELHFGEGVHRKAFRSKVMQGLM-----------------------------PVFQPGHACVLKVHNAVAHGTRNNDEL
Melanoma K	 58 QLGLCAKIEFLSKEEMGGGLRRAVKVLCTWSEH-----------------------------DILKSGHLYIIKSFLPEVINTWSSIYK
Ch 4 K	 1027 AQETIVYLGDYLTVKKKGRQRNAFWVHHLHQEEIL---------------------------------GRYVGKDYKEQ----------
Consensus     *******o*o****F**G*oR*Ao****o*****************************************oV*K*o*************
III IV 
II
V
H. EF-2K	 178 ----RDVYFEDVRLQMEAKLWGEEYNR----HKPPKQVDIMQMCIIELKDR----PGKPLF-HLEHYIEGKYIKYNSNSGFVRDDNI----
C.e. EF-2K	 162 ----RRVLFDDVRLQMDAKLWAEEYNR----YNPPKKIDIVQMCVIEMIDV----KGSPLY-HLEHFIEGKYIKYNSNSGFVSNAA-----
MHCK A	 653 QQASRELYFEDVKMQMVCRDWGNKFNQ----KKPPKKIEFLMSWVVELIDRSPSSNGQPILCSIEPLLVGEFKKNNSNYGAVLTN------
MHCK B	 177 -PTPRPSYFEDVKMQMIAKKWADKYNS----FKPPKKIEFLQSCVLEFVDRTSSD----LICGAEPYVEGQYRKYNNNSGFVSNDE-----
MhkC	 89 --TTRDSYFTDVLMQTFCAKWAEKFNE----AKPPKPITFLPSYVYELIDHPPPY---PV-CGGEPFIEGDYKKHNNNSGYVSSDA-----
Heart K	 249 VQRNYKLAAQECYVQNTARYYAKIYAA----EAQPLEGFGEVPEIIPIFLIHRPENNIPY-ATVEEELIGEFVKYSIRDGKEINFLRRDSE
Melanoma K	118 EDTVLHLCLREIQQQRAAQKLTFAFNQ----MKP-KSIPYSP-RFLEVFLLYCHSAGQ-WFA-VEECMTGEFRKYNNNNGDEIIPTNTL--
Ch 4 K	 1073 --KGLWHHFTDVERQMTAQHYVTEFNKRLYEQNIPTOIFYIPSTILLILEDKTI-KGC-I--SVEPYILGEFVKLSNNTKVVKTEYK----
Consensus     ******ooF*DV*oQ**A**o***oN*******PPK*I*oo***ooEoo**********o***oE*oo*G*o*KoN*N*G*V*********
VI VII VIII
H. EF-2K	 252 -RLTPQAFSHFTFERSGHQLIVVDIQGVGD-------LYTDPQIHTET-----GTDFGDGNLGVRGMALFFY-SH-ACNRICESMGLAPF
C.e. EF-2K	 235 -RLTPQAFSHFTFERSGHQMMVVDIQGVGD-------LYTDPQIHTVV-----GTDYGDGNLGTRGMALFFH-SH-RCNDICETMDLSNF
MHCK A	 734 -RSTPQAFSHFTYELSNKQMIVVDIQGVDD-------LYTDPQIHTPD-----GKGFGLGNLGKAGINKFIT-TH-KCNAVCALLDL-DV
MHCK B	 254 -RNTPQSFSHFTYEHSNHQLLIIDIQGVGD-------HYTDPQIHTYD-----GVGFGIGNLGQKGFEKFLD-TH-KCNAICQYLNLQSI
MhkC	 165 -RNTPQSFSHFSYELSNHELLIVDIQGVND-------FYTDPQIHTKS-----GEGFGEGNLGETGFHKFLQ-TH-KCNPVCDFLKLKPI
Heart K	 335 AGQKCCTFQHWVYQKTSGCLLVTDMQGVGM-------KLTDVGIATLAR---GYKGF-KGNCSMTFIDQFRA-LH-QCNKYCKMLGLKSL
Melanoma K	199 -EEIMLAFSHWTYEYTRGELLVLDLQGVGE-------NLTDPSVIKAEEKRSCDMVFGPANLGEDAIKNFRA-KH-HCNSCCRKLKLPDL
Ch 4 K	 1153 ATEYGLAYGHFSYEFSNHRDVVVDLQGWVTGNGKGLIYLTDPQIHSVD-----QKVF-TTNFGKRGIFYFFNNQHVECNEICHRLSLTRP 
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irregular regions that have a flexible
conformation (reviewed in [11]).
Recently, it was shown both for an
insulin receptor tyrosine kinase and
for phosphorylase kinase that
binding of the active site to the
substrate involves the formation of a
short antiparallel β sheet between
the substrate and the activation loop
of the kinase [12,13]. It is likely that
the irregular, flexible structure of
the substrates of conventional
protein kinases may be necessary for
formation of the β sheet at the
active site. 
In contrast to this, existing
evidence suggests that the peptides
around the phosphorylation sites in
eEF-2 and Dictyostelium myosin II
heavy chains have an α-helical
conformation. The two MHCK A
phosphorylation sites are located in a
coiled-coil α-helical region of myosin
heavy chains [14]. Sequences
surrounding the two MHCK A
phosphorylation sites are very
different; in both cases, however, the
phosphoacceptor threonine residues
are located in the same position in
the heptad repeat of the coiled-coil
[14], suggesting that secondary
structure rather than primary
structure is the determinant for this
protein kinase. The major
phosphorylation site in eEF-2
(Thr56) is located within a sequence
that is homologous among all
elongation factors. It can be seen
from the crystal structure of EF-Tu
that this site has an α-helical
conformation [15,16]. These findings
suggest an explanation for why 
eEF-2 kinase and MHCK A are so
different from the conventional
protein kinases: their catalytic
domain may be adapted to recognize
and phosphorylate amino acids
located within α helices. We suggest,
therefore, that this new class of
protein kinases be named ‘alpha-
kinases’ (α-kinases). Intriguingly,
both eEF-2 kinase and MHCK A
phosphorylate their substrates
exclusively on threonine residues. It
was recently shown that
phosphothreonine, but not
phosphoserine, can destabilize
α helices [17]. Phosphorylation of
α helices on threonine residues
could therefore lead to a drastic
alteration in protein structure
affecting the function of the
substrate proteins. 
No matter what mechanism they
use for substrate recognition, 
α-kinases clearly have a new type of
kinase catalytic domain,
characterized by a unique set of
motifs. Previously, two types of
protein kinase catalytic domains
were known and characterized: the
catalytic domain of eukaryotic
serine/threonine/tyrosine protein
kinases, and the catalytic domain of
histidine protein kinases of bacterial
two-component regulators. The
three-dimensional structure of a
bacterial histidine kinase has been
determined recently and was found
to be completely different from the
conventional eukaryotic protein
kinases [18]. It is interesting that the
glycine-rich motif in histidine
kinases is located close to the
carboxyl terminus of the catalytic
domain, which is similar to the
location of the glycine-rich motif in
α-kinases. Further studies are
required to find out whether this is
purely a coincidence, or whether 
α-kinases and histidine kinases are
evolutionarily related. 
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